Our mission highlights patient-centric programs that align with the FDA's patient-focused drug development (PFDD) paradigm. These initiatives include the Diversity Patients Alliance Program, a tech-enabled Patients Concierge, the Corporate Diversity Advisory Council (CDAC), research programs, and national and international conferences, all aimed at providing substantial support and engagement for those affected.
Indo US Organization for Rare Diseases
Business Area
About

